TTK Healthcare Ltd.

TTK Healthcare has reached a new 52-week low, continuing a downward trend after two days of gains. The stock is trading below multiple moving averages, indicating a bearish outlook. Over the past year, it has declined significantly, contrasting with the overall market performance.

TTK Healthcare, a small-cap pharmaceutical company, is nearing its 52-week low, trading just above it. Despite a recent trend reversal, the stock has shown erratic trading patterns and remains below key moving averages. Over the past year, it has declined significantly compared to the broader market.

TTK Healthcare has reached a new 52-week low, reflecting a significant decline in its stock performance over the past year, underperforming the broader market. Despite today's drop, it outperformed its sector slightly. The stock has shown erratic trading patterns and is currently below multiple moving averages.

TTK Healthcare has reached a new 52-week low, reflecting a significant decline in its stock performance over the past year, underperforming the broader market. Despite today's drop, it outperformed its sector slightly. The stock has shown erratic trading patterns and is currently below multiple moving averages.

TTK Healthcare has reached a new 52-week low, reflecting a significant decline in its stock performance over the past year, underperforming the broader market. Despite today's drop, it outperformed its sector slightly. The stock has shown erratic trading patterns and is currently below multiple moving averages.

TTK Healthcare has reached a new 52-week low, reflecting a significant decline in its stock performance over the past year, underperforming the broader market. Despite today's drop, it outperformed its sector slightly. The stock has shown erratic trading patterns and is currently below multiple moving averages.

TTK Healthcare has faced significant volatility, reaching a new 52-week low and underperforming its sector. The stock has seen a consecutive decline over two days, with erratic trading patterns and a sustained downward trend below key moving averages. Its one-year return contrasts sharply with broader market performance.

TTK Healthcare, a small-cap in the Pharmaceuticals & Drugs sector, is nearing a 52-week low while showing notable performance today, outperforming its sector. Despite this, the stock remains below key moving averages and has declined over the past year, contrasting with broader market trends.

TTK Healthcare announced its third-quarter financial results for FY24-25, reporting a significant increase in Profit Before Tax to Rs 4.75 crore and Profit After Tax at Rs 16.73 crore. However, the company faces challenges with a declining inventory turnover ratio and a high reliance on non-operating income.

TTK Healthcare has reached a 52-week low amid ongoing market challenges, with a recent decline contributing to a total return of -1.72% over two days. The stock is trading below key moving averages and has underperformed over the past year compared to the broader Sensex index.

TTK Healthcare, a small-cap pharmaceutical company, has hit a 52-week low amid ongoing challenges, trailing its sector. The stock is trading below key moving averages, reflecting a downward trend, and has declined 5.10% over the past year, contrasting with the Sensex's 8.08% gain.

TTK Healthcare has recently experienced a revision in its score by MarketsMOJO, reflecting concerns over its long-term growth and inventory management. Despite some positive financial metrics, the stock's performance has lagged behind the market, prompting a reassessment of its investment potential. The company has been added to MarketsMOJO's list, indicating a cautious outlook.

TTK Healthcare has recently been added to MarketsMOJO's list following a revision in its score. Despite a notable increase in stock price, the company continues to face challenges, underperforming its sector significantly. Investors are advised to monitor TTK Healthcare's ongoing performance and market developments closely.

TTK Healthcare, a smallcap pharmaceutical and drugs company, has been downgraded to 'Sell' by MarketsMOJO due to poor long-term growth, flat recent results, and low interest from domestic mutual funds. The company's technical trend has also deteriorated, and it is currently trading at a premium compared to its historical valuations. Investors should carefully consider these factors before making any decisions.

TTK Healthcare, a smallcap pharmaceutical company, has reported a flat performance in the quarter ending September 2024. The company's dividend per share has been consistently high for the past five years, but there are concerns about its non-operating income being a major contributor to profits. MarketsMOJO advises holding the stock.

TTK Healthcare Ltd. has reached a new milestone in its stock price, hitting a 52-week high of Rs. 1890.05 on September 10, 2024. The company has outperformed the sector and has shown consecutive gains in the last 2 days. With a 'Hold' recommendation from MarketsMOJO and a strong 1-year performance, TTK Healthcare is a promising smallcap company in the pharmaceutical and drugs industry.